|
2023 Conference Publication Pareidolias are related to visuoperceptual abilityMcCann, Emily, Lee, Soohyun, Coleman, Felicia, O'Sullivan, John and Nestor, Peter (2023). Pareidolias are related to visuoperceptual ability. Australia Dementia Research Forum, Gold Coast, QLD Australia, 29 - 31 May 2023. |
|
2023 Conference Publication Case Study: Patient HL, Parkinson’s DiseaseMcCann, Emily, Lee, Soohyun, Coleman, Felicia, O'Sullivan, John and Nestor, Peter (2023). Case Study: Patient HL, Parkinson’s Disease. Cognition and Basal Ganglia Club, Brisbane, QLD Australia, March 2023. |
|
2023 Conference Publication Pareidolias as misperceptions in Lewy Body DisordersMcCann, Emily, Lee, Soohyun, Coleman, Felicia, O'Sullivan, John and Nestor, Peter (2023). Pareidolias as misperceptions in Lewy Body Disorders. Clem Jones Centre for Ageing and Dementia Research (CJCADR) Scientific Symposium, Brisbane, QLD Australia, 9 February 2023. |
|
2022 Conference Publication Update on TRIP: Therapy to reduce dementia risk in Parkinson’s disease proof of concept trialPourzinal, D., Bakker, A., Byrne, G.J., McMahon, K., O’Sullivan, J.D., Adam, R., Lehn, A., Copland, D., Yang, J.H., Au, T., Littleford, R., Chatfield, M., Pontone, G., Mari, Z. and Dissanayaka, N. (2022). Update on TRIP: Therapy to reduce dementia risk in Parkinson’s disease proof of concept trial. UQ Centre for Clinical Research HDR Symposium, Brisbane, QLD Australia, 24 November 2022. |
|
2022 Conference Publication LC-MS based urine metabolomic profiling indicate altered gut microbiome and host lipid metabolites in Parkinson's diseaseJewell, Shannon, Roper, Kerry, Woodhouse, Helen, Adam, Robert, O'Sullivan, John and Gordon, Richard (2022). LC-MS based urine metabolomic profiling indicate altered gut microbiome and host lipid metabolites in Parkinson's disease. Experimental Biology 2022 Meeting, Philadelphia, PA United States, 2-5 April 2022. Hoboken, NJ United States: John Wiley and Sons. doi: 10.1096/fasebj.2022.36.S1.R2928 |
|
2022 Conference Publication A Novel Role for Glucocerebrosidase 1 (GBA1) in Parkinson's DiseaseJayabalan, Nanthini, Roper, Katherine Kerry, Woodhouse, Helen M., Adam, Robert J., O'Sullivan, John D. and Gordon, Richard (2022). A Novel Role for Glucocerebrosidase 1 (GBA1) in Parkinson's Disease. Experimental Biology Meeting 2022, Philadelphia, PA United States, 2-5 April 2022. Hoboken, NJ United States: John Wiley and Sons. doi: 10.1096/fasebj.2022.36.S1.R5391 |
|
2022 Conference Publication Update on TRIP: Therapy to reduce dementia risk in Parkinson’s disease proof of concept trialPourzinal, D., Bakker, A., Byrne, G.J., McMahon, K., O’Sullivan, J.D., Adam, R., Lehn, A., Copland, D., Yang, J.H., Au, T., Littleford, R., Chatfield, M., Pontone, G., Mari, Z. and Dissanayaka, N. (2022). Update on TRIP: Therapy to reduce dementia risk in Parkinson’s disease proof of concept trial. UQ Neurosciences Symposium, Brisbane, QLD Australia, 26-27 September 2022. |
|
2021 Conference Publication Using N-of-1 tests to identify responders to melatonin for sleep disturbance in Parkinson’s DiseaseNikles, J., Mitchell, G. K., Smith, S. S., McGree, J. M., McDonald, S., Poli, N., Senior, H., Tan, S., Dissanyaka, N., Ritchie, A. and O'Sullivan, J. D. (2021). Using N-of-1 tests to identify responders to melatonin for sleep disturbance in Parkinson’s Disease. Australian Clinical Trials Alliance conference, Sydney, NSW, Australia, November 2021. |
|
2021 Conference Publication Therapy to reduce dementia risk in Parkinson’s disease (TRIP): Proof-of-concept protocolPourzinal, D., Bakker, A., Byrne, G.J., McMahon, K., O’Sullivan, J., Adam, R., Copland, D., Yang, J.H.J., Au, T., Littleford, R., Chatfield, M., Pontone, G., Mari, Z. and Dissanayaka, N. (2021). Therapy to reduce dementia risk in Parkinson’s disease (TRIP): Proof-of-concept protocol. Australia Dementia Forum 2021, Online, 31 May - 1 June 2021. |
|
2021 Conference Publication Investigating resting state functional connectivity in sub-phenotypes of mild cognitive impairment in Parkinson’s diseasePourzinal, D., Yang, J.H., Byrne, G.J., O’Sullivan, J.D., McMahon, K., Copland, D.A. and Dissanayaka, N. (2021). Investigating resting state functional connectivity in sub-phenotypes of mild cognitive impairment in Parkinson’s disease. Australia Dementia Forum 2021, Online, 31 May – 1 June 2021. |
|
2020 Conference Publication Anxiety disorders are associated with verbal memory impairment in patients with Parkinson’s disease without dementiaForbes, E., Byrne, G. J., Yang, J. H. J., O'Sullivan, J., Copland, D. A., McMahon, K. L., Mitchell, L. K. and Dissanayaka, N. N. (2020). Anxiety disorders are associated with verbal memory impairment in patients with Parkinson’s disease without dementia. Herston Health Precinct Symposium 2020, Brisbane, QLD, Australia, 7-11 December 2020. |
|
2020 Conference Publication Improving diagnosis and treatment of anxiety in Parkinson’s disease: IDATA-PD study updateDissanayaka, N., Byrne, G. J., Mitchell, L. K., O'Sullivan, J. D., Padmassini, A., White, E. X., Yang, J. H. J., Forbes, E., Thangavelu, K., Au, T., Lehn, A., Adam, R. and Pachana, N. A. (2020). Improving diagnosis and treatment of anxiety in Parkinson’s disease: IDATA-PD study update. Herston Health Precinct Symposium 2020, Brisbane, QLD Australia, 7-11 December 2020. |
|
2020 Conference Publication Therapy to reduce dementia risk in Parkinson’s disease (TRIP): proof-of-concept protocolPourzinal, D., Bakker, A., Byrne, G. J., McMahon, K., O'Sullivan, J., Adam, R., Copland, D., Yang, J. H. J., Au, T., Littleford, R., Chatfield, M., Pontone, G., Mari, G. and Dissanayaka, N. (2020). Therapy to reduce dementia risk in Parkinson’s disease (TRIP): proof-of-concept protocol. Herston Health Precinct Symposium 2020, Brisbane, QLD Australia, 7-11 December 2020. |
|
2020 Conference Publication Neural correlates of semantic fluency deficits in Parkinson’s disease patients with mild cognitive impairmentYang, J., Copland, D., McMahon, K., Byrne, G., O'Sullivan, J. and Dissanayaka, N. (2020). Neural correlates of semantic fluency deficits in Parkinson’s disease patients with mild cognitive impairment. Herston Health Precinct Symposium 2020, Brisbane, QLD, Australia, 7-11 December 2020. |
|
2020 Conference Publication Therapy to Reduce dementia risk In Parkinson’s disease (TRIP): proof-of-concept protocolPourzinal, D., Bakker, A., Byrne, G. J., McMahon, K., O'Sullivan, J., Adam, R., Copland, D., Yang, J. H. J., Au, T., Littleford, R., Chatfield, M., Pontone, G., Mari, Z. and Dissanayaka, N. (2020). Therapy to Reduce dementia risk In Parkinson’s disease (TRIP): proof-of-concept protocol. UQ Faculty of Medicine Higher Degree by Research Student Symposium, Brisbane, QLD Australia, 23-27 November 2020. |
|
2020 Conference Publication Altered functional connectivity of the hippocampus in posterior-cortical subtype of cognitive impairment in Parkinson’s diseasePourzinal, D., Yang, J. H., Byrne, G. J., O'Sullivan, J. D., Mitchell, L. K., McMahon, K. L., Copland, D. A. and Dissanayaka, N. N. W. (2020). Altered functional connectivity of the hippocampus in posterior-cortical subtype of cognitive impairment in Parkinson’s disease. Australian Society for Medical Research Queensland Postgraduate Student Conference, Online, 11 November 2020. |
|
2020 Conference Publication Defining atypical anxiety in Parkinson’s diseaseForbes, E., Byrne, G. J., Yang, J. H. J., O'Sullivan, J., Copland, D. A., McMahon, K. L., Mitchell, L. K. and Dissanayaka, N. N. (2020). Defining atypical anxiety in Parkinson’s disease. Herston Health Precinct Symposium 2020, Brisbane, QLD, Australia, 7-11 December 2020. |
|
2020 Conference Publication Identification and clinical characteristics of mild cognitive impairment in Parkinson's diseaseYang, J., Forbes, E., Pourzinal, D., McMahon, K., Copland, D., Byrne, G., O'Sullivan, J., Mitchell, L. and Dissanayaka, N. (2020). Identification and clinical characteristics of mild cognitive impairment in Parkinson's disease. Herston Health Precinct Symposium 2020, Brisbane, QLD, Australia, 7-11 December 2020. |
|
2020 Conference Publication Profiling atypical anxiety in Parkinson’s DiseaseForbes, E., Byrne, G.J., Yang, J.H.J., O'Sullivan, J., Copland, D.A., McMahon, K.L., Mitchell, L.K. and Dissanayaka, N.N. (2020). Profiling atypical anxiety in Parkinson’s Disease. MDS Virtual Congress 2020, Online, 12-16 September 2020. |
|
2020 Conference Publication Using cluster analysis to identify mild cognitive impairment phenotypes in Parkinson’s diseasePourzinal, D., Yang, J.H.J., Byrne, G.J., O'Sullivan, J., Mitchell, L., McMahon, K.L., Copland, D.A. and Dissanayaka, N.N. (2020). Using cluster analysis to identify mild cognitive impairment phenotypes in Parkinson’s disease. 5th Annual NHMRC National Institute for Dementia Research (NNIDR) Australian Dementia Forum, Adelaide, Australia, 31 May - 2 June 2020. |
